NCT05731050: Study of NM8074 in Soliris-Treated Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
- State
- Not started
- Phase
- Phase 2
- People
- 6 planned
- Started
- Jun 2026
- Primary completion
- Sep 2027
- Arms
- NM8074
- Results
- None posted
- 16 Feb 2023: Trial registered